Compare · AVCO vs GYRO
AVCO vs GYRO
Side-by-side comparison of Avalon GloboCare Corp. (AVCO) and Gyrodyne LLC (GYRO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AVCO and GYRO operate in Building operators (Real Estate), so they compete in similar markets.
- AVCO is the larger of the two at $66.1M, about 3.5x GYRO ($18.9M).
- Company
- Avalon GloboCare Corp.
- Gyrodyne LLC
- Price
- $0.56-11.07%
- $7.47-14.82%
- Market cap
- $66.1M
- $18.9M
- 1M return
- -
- -14.82%
- 1Y return
- -
- -21.45%
- Industry
- Building operators
- Building operators
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 0
Avalon GloboCare Corp.
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. It also develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology. In addition, the company develops proprietary diagnostic and therapeutic products leveraging exosome technology; and provides development services for hospitals. The company has a strategic partnership with Weill Cornell Medical College to co-develop bio-production and standardization procedures for chimeric antigen receptor (CAR)-T Therapy; GensKey Medical Technology Co. Ltd. to co-develop and commercialize point-of-care, rapid detection antibody tests to identify whether a patient has been exposed to and has developed antibodies against SARS-CoV-2; GE Healthcare to enhance standardized automation and bio-production for cellular medicines; and HydroPeptide, LLC to co-develop and commercialize various clinical-grade, exosome-based cosmeceutical and orthopedic products, as well as research agreement with Massachusetts Institute of Technology to develop CAR technology. It also has a collaboration agreement with the UPMC Hillman Cancer Center to advance the clinical development and production of CAR therapies using FLASH CAR technology. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey.
Gyrodyne LLC
Gyrodyne, LLC. owns, leases and manages diverse commercial properties. The firm is distinguished by its service-oriented philosophy toward property ownership and management. Gyrodyne has grown from a largely Long Island player during the past into a diversified East Coast presence with an emphasis on medical office product.
Latest AVCO
- SEC Form SC 13D/A filed by Avalon GloboCare Corp. (Amendment)
- Avalon GloboCare Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form 10-Q filed by Avalon GloboCare Corp.
- Avalon GloboCare Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- SEC Form D filed by Avalon GloboCare Corp.
- Avalon GloboCare Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- Avalon GloboCare Corp. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders
- SEC Form ARS filed by Avalon GloboCare Corp.
- SEC Form DEF 14A filed by Avalon GloboCare Corp.
- Avalon GloboCare Corp. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Latest GYRO
- SEC Form 10-K filed by Gyrodyne LLC
- Gyrodyne LLC filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- SEC Form 10-Q filed by Gyrodyne LLC
- Gyrodyne LLC filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Gyrodyne LLC filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form DEF 14A filed by Gyrodyne LLC
- Gyrodyne LLC filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Gyrodyne Announces Agreement with Star Equity Fund
- Large owner Towerview Llc sold $24,761 worth of shares (1,973 units at $12.55), decreasing direct ownership by 0.58% to 338,107 units (SEC Form 4)
- SEC Form PREC14A filed by Gyrodyne LLC